NP promised a roadmap for HIV BLA during the previ
Post# of 148161
Granted, it's just a roadmap, but it's a chance to set expectations going forward and doing it properly and meeting those milestones would go a long way to sooth some of the more anxious investors' nerves.
The covid updates I'm not expecting anything definitive, just updates as to progress with the Big 3 (Canada, UK, US)... Philippines and Brazil sounded at the "hopefully" stage.
Cancer and NASH just looking forward to enrollment status, maybe some anecdotal events.. the last call I think was done a bit hastily and wasn't as complete as everyone would have liked (even though they were much more organized and presented much better than in previous calls).
Not sure there's a massive hurry; if someone didn't pick any up between $2-$2.50 already after the call announcement, what's compelling them to buy now?